| Primary |
| Diabetes Mellitus |
17.6% |
| Prostate Cancer |
15.7% |
| Type 2 Diabetes Mellitus |
15.7% |
| Hypertension |
9.8% |
| Bipolar Disorder |
3.9% |
| Blood Glucose Increased |
3.9% |
| Hyperlipidaemia |
3.9% |
| Left Ventricular Dysfunction |
3.9% |
| Stent Placement |
3.9% |
| Angina Pectoris |
2.0% |
| Anticoagulant Therapy |
2.0% |
| Atrial Fibrillation |
2.0% |
| Blood Glucose |
2.0% |
| Blood Pressure |
2.0% |
| Cardiovascular Event Prophylaxis |
2.0% |
| Chest Pain |
2.0% |
| Cholesterol |
2.0% |
| Coronary Artery Disease |
2.0% |
| Diabetes |
2.0% |
| Diabetes Mellitus Non-insulin-dependent |
2.0% |
|
| Blood Glucose Increased |
13.8% |
| Muscular Weakness |
13.8% |
| Weight Decreased |
10.3% |
| Vision Blurred |
6.9% |
| Biliary Tract Disorder |
3.4% |
| Cardiac Failure Congestive |
3.4% |
| Cerebrovascular Accident |
3.4% |
| Chronic Obstructive Pulmonary Disease |
3.4% |
| Condition Aggravated |
3.4% |
| Diabetic Retinopathy |
3.4% |
| Dizziness |
3.4% |
| Drug Interaction |
3.4% |
| Hearing Impaired |
3.4% |
| Hormone Level Abnormal |
3.4% |
| Hypoglycaemia |
3.4% |
| Hypoglycaemic Unconsciousness |
3.4% |
| Malaise |
3.4% |
| Medication Error |
3.4% |
| Musculoskeletal Disorder |
3.4% |
| Myocardial Infarction |
3.4% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
57.9% |
| Diabetes Mellitus |
13.7% |
| Hypertension |
5.3% |
| Diabetes Mellitus Non-insulin-dependent |
4.2% |
| Bipolar Disorder |
2.1% |
| Blood Glucose |
2.1% |
| Hyperlipidaemia |
2.1% |
| Psoriasis |
2.1% |
| Angina Pectoris |
1.1% |
| Blood Cholesterol |
1.1% |
| Cardiovascular Event Prophylaxis |
1.1% |
| Hypothyroidism |
1.1% |
| Insomnia |
1.1% |
| Osteoarthritis |
1.1% |
| Pneumonia |
1.1% |
| Prophylaxis |
1.1% |
| Rheumatoid Arthritis |
1.1% |
| Type 1 Diabetes Mellitus |
1.1% |
|
| Blood Glucose Increased |
17.5% |
| Drug Ineffective |
10.0% |
| Glycosylated Haemoglobin Increased |
10.0% |
| Vomiting |
10.0% |
| Hypoglycaemia |
7.5% |
| Weight Decreased |
7.5% |
| Nausea |
5.0% |
| Abdominal Pain Upper |
2.5% |
| Blood Glucose Fluctuation |
2.5% |
| Diabetes Mellitus Inadequate Control |
2.5% |
| Drug Hypersensitivity |
2.5% |
| Loss Of Consciousness |
2.5% |
| Malaise |
2.5% |
| Memory Impairment |
2.5% |
| Myocardial Infarction |
2.5% |
| Pain |
2.5% |
| Pneumonia |
2.5% |
| Pruritus Generalised |
2.5% |
| Renal Impairment |
2.5% |
| Sepsis |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
17.5% |
| Diabetes Mellitus |
17.3% |
| Type 2 Diabetes Mellitus |
15.0% |
| Drug Use For Unknown Indication |
10.9% |
| Hypertension |
8.9% |
| Uveitis |
4.7% |
| Diabetes Mellitus Non-insulin-dependent |
4.6% |
| Pain |
3.8% |
| Nuclear Magnetic Resonance Imaging |
2.9% |
| Prophylaxis |
1.6% |
| Anxiety |
1.5% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Hyperglycaemia |
1.4% |
| Cardiovascular Event Prophylaxis |
1.3% |
| Arthritis |
1.2% |
| Blood Cholesterol Increased |
1.2% |
| Depression |
1.2% |
| Menopause |
1.1% |
| Vitamin Supplementation |
1.1% |
| Schizophrenia |
1.0% |
|
| Myocardial Infarction |
28.2% |
| Weight Decreased |
11.3% |
| Pain |
8.6% |
| Coronary Artery Disease |
5.2% |
| Weight Increased |
5.2% |
| Blood Glucose Increased |
4.4% |
| Vomiting |
4.1% |
| Cerebrovascular Accident |
3.6% |
| Myocardial Ischaemia |
3.6% |
| Nausea |
3.6% |
| Pulmonary Congestion |
3.0% |
| Transient Ischaemic Attack |
2.8% |
| Hypoglycaemia |
2.5% |
| Tremor |
2.5% |
| Vision Blurred |
2.5% |
| Cardiac Failure Congestive |
1.9% |
| Renal Failure |
1.9% |
| Death |
1.7% |
| Drug Ineffective |
1.7% |
| Hypertension |
1.7% |
|
